China Pharma Stock Forecast - Daily Balance Of Power
| CPHI Stock | USD 0.20 0.01 5.26% |
China Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of China Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
China |
| Check China Pharma Volatility | Backtest China Pharma | Trend Details |
China Pharma Trading Date Momentum
| On September 19 2024 China Pharma Holdings was traded for 0.22 at the closing time. The top price for the day was 0.23 and the lowest listed price was 0.21 . The trading volume for the day was 169.2 K. The trading history from September 19, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.35% . The overall trading delta against the current closing price is 8.70% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare China Pharma to competition |
Other Forecasting Options for China Pharma
For every potential investor in China, whether a beginner or expert, China Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. China Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in China. Basic forecasting techniques help filter out the noise by identifying China Pharma's price trends.View China Pharma Related Equities
| Risk & Return | Correlation |
China Pharma Holdings Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of China Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of China Pharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
China Pharma Market Strength Events
Market strength indicators help investors to evaluate how China Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading China Pharma shares will generate the highest return on investment. By undertsting and applying China Pharma stock market strength indicators, traders can identify China Pharma Holdings entry and exit signals to maximize returns.
China Pharma Risk Indicators
The analysis of China Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in China Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting china stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.36 | |||
| Semi Deviation | 4.83 | |||
| Standard Deviation | 7.0 | |||
| Variance | 49.05 | |||
| Downside Variance | 60.69 | |||
| Semi Variance | 23.29 | |||
| Expected Short fall | (9.22) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether China Pharma Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Pharma Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Pharma Holdings Stock:Check out Historical Fundamental Analysis of China Pharma to cross-verify your projections. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China Pharma. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share 0.63 | Quarterly Revenue Growth (0.16) | Return On Assets (0.18) | Return On Equity (0.75) |
The market value of China Pharma Holdings is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China Pharma's value that differs from its market value or its book value, called intrinsic value, which is China Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China Pharma's market value can be influenced by many factors that don't directly affect China Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.